Delivery Order SPE2DR25D2013-SPE2DR26F5RDA

The Defense Logistics Agency awarded a delivery order valued at $37,793.70 to AmerisourceBergen Drug Corp for the supply of Trelegy Ellipta 100-62.5-25, a combination inhalation powder medication used in respiratory disease management. This firm fixed-price, non-set-aside contract was awarded on January 30, 2026, with an ultimate completion date of February 2, 2026. The product will be delivered to the company's headquarters location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for supplying a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, regularly supplies medications, vaccines, medical devices, and specialized healthcare commodities to military treatment facilities and veteran healthcare systems through competitive procurement processes. The company's role as a prime vendor within the DLA Troop Support Medical supply chain demonstrates its established capability to meet federal pharmaceutical distribution requirements. This delivery order represents one of many task orders executed under the broader IDC agreement, continuing the company's mission to provide essential pharmaceutical support across multiple therapeutic domains to Department of Defense healthcare operations.